Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Preti

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Leukemia Research|July 18, 2009
Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibitionJianguo Wen, Yongdong Feng, Wanting Huang, et al.
Bone Marrow Transplantation|April 4, 2000
Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord bloodA L Pecora, P Stiff, A Jennis, et al.
Genomics|February 14, 2004
Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene familyE Monti, M T Bassi, R Bresciani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipientsA L Pecora, R A Preti, G W Gleim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC seriesA López-Guillermo, F Cabanillas, P McLaughlin, et al.
British Journal of Haematology|February 1, 1997
Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trialA Younes, J P Ayoub, A Sarris, et al.
Blood|May 16, 1998
The clinical significance of molecular response in indolent follicular lymphomasA López-Guillermo, F Cabanillas, P McLaughlin, et al.
Leukemia & Lymphoma|March 28, 1998
Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patientsJ E Romaguera, J Rodríguez Díaz-Pavon, L Carías, et al.
Journal of Fish Biology|May 23, 2015
Insights into the life history and ecology of a large shortfin mako shark Isurus oxyrinchus captured in southern CaliforniaK Lyons, A Preti, D J Madigan, et al.
Bone Marrow Transplantation|March 1, 1997
Single and double autotransplants for relapsing/refractory Hodgkin's disease: results of two consecutive trialsT Ahmed, D E Lake, M Beer, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Leukemia Research|July 18, 2009
Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibitionJianguo Wen, Yongdong Feng, Wanting Huang, et al.
Bone Marrow Transplantation|April 4, 2000
Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord bloodA L Pecora, P Stiff, A Jennis, et al.
Genomics|February 14, 2004
Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene familyE Monti, M T Bassi, R Bresciani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipientsA L Pecora, R A Preti, G W Gleim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC seriesA López-Guillermo, F Cabanillas, P McLaughlin, et al.
British Journal of Haematology|February 1, 1997
Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trialA Younes, J P Ayoub, A Sarris, et al.
Blood|May 16, 1998
The clinical significance of molecular response in indolent follicular lymphomasA López-Guillermo, F Cabanillas, P McLaughlin, et al.
Leukemia & Lymphoma|March 28, 1998
Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patientsJ E Romaguera, J Rodríguez Díaz-Pavon, L Carías, et al.
Journal of Fish Biology|May 23, 2015
Insights into the life history and ecology of a large shortfin mako shark Isurus oxyrinchus captured in southern CaliforniaK Lyons, A Preti, D J Madigan, et al.
Bone Marrow Transplantation|March 1, 1997
Single and double autotransplants for relapsing/refractory Hodgkin's disease: results of two consecutive trialsT Ahmed, D E Lake, M Beer, et al.
Pageof 17